A novel nonradioactive method to evaluate vascular barrier breakdown and leakage

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 3, 2010, Pages 1677-1682

  Trichonas, George ^a   Manola, Akrivi ^a   Morizane, Yuki ^a   Thanos, Aristomenis ^a   Koufomichali, Xanthi ^a   Papakostas, Thanos D ^a   Montezuma, Sandra ^a   Young, Lucy ^a   Miller, Joan W ^a   Gragoudas, Evangelos ^a   Vavvas, Demetrios ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; PHOSPHATE BUFFERED SALINE; DIAGNOSTIC AGENT; LIPOPOLYSACCHARIDE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INFLAMMATION; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; NONRADIOACTIVE MICROLEAKAGE ASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RETINA BLOOD VESSEL; RETINA DISEASE; TISSUE LEVEL; WESTERN BLOTTING; ANIMAL; BIOTINYLATION; BROWN NORWAY RAT; C57BL MOUSE; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; PATHOLOGY;

ANIMALS; BIOTINYLATION; BLOOD-RETINAL BARRIER; BLOTTING, WESTERN; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOPRECIPITATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, INBRED BN; RETINAL VESSELS; SERUM ALBUMIN, BOVINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949888782     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4193     Document Type: Article

References (25)

1. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
2. Bamforth SD, Lightman S, Greenwood J. The effect of TNF-alpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo. Acta Neuropathol. 1996;91:624-632.
3. Tilton RG, Kawamura T, Chang KC, et al. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest. 1997;99:2192-2202.
4. Stitt AW, Bhaduri T, McMullen CB, Gardiner TA, Archer DB. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats. Mol Cell Biol Res Commun. 2000;3:380-388.
5. Shyong M-P, Lee F-L, Kuo P-C, et al. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector. Mol Vis. 2007;13:133-141.
6. Ishida S, Usui T, Yamashiro K, et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci. 2003;44:2155-2162.
7. Harada M, TM, Fukao T, Katagiri K. A simple method for the quantitative extraction of dye extravasated into the skin. J Pharm Pharmacol. 1971;23:218-219.
8. Xu Q, Qaum T, Adamis AP. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci. 2001;42:789-794.
9. Drake WT, Creighan M, Sims DE. Limitations of monastral blue as a vascular label: rapid rate of clearance is age-dependent, and interactions with anesthetics depress arterial blood pressure in rats. Microsc Res Tech. 1992;23:219-224.
10. Hafezi-Moghadam A, Thomas KL, Wagner DD. ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage. Am J Physiol Cell Physiol. 2007;292: C1256-C1262.
11. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996;103:1820-1828.
12. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxininduced uveitis in rats as a model for human disease. Nature. 1980;286:611-613.
13. Yi ES, Ulich TR. Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules. Am J Pathol. 1992;140:659-663.
14. Vavvas D, Apazidis A, Saha AK, et al. Contraction-induced changes in acetyl-CoA carboxylase and 5-AMP-activated kinase in skeletal muscle. J Biol Chem. 1997;272:13255-13261.
15. Sinitsyn VV, Mamontova AG, Checkneva YY, Shnyra AA, Domogatsky SP. Rapid blood clearance of biotinylated IgG after infusion of avidin. J Nucl Med. 1989;30:66-69.
16. Derevjanik NL, Vinores SA, Xiao WH, et al. Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest Ophthalmol Vis Sci. 2002;43:2462-2467.
17. McDonald DM, Thurston G, Baluk P. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation. 1999;6:7-22.
18. Udaka K, Takeuchi Y, Movat HZ. Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med. 1970;133: 1384-1387.
19. Vaz R, Sarmento A, Borges N, Cruz C, Azevedo T. Experimental traumatic cerebral contusion: morphological study of brain microvessels and characterization of the oedema. Acta Neurochir (Wien). 1998;140:76-81.
20. Chen I, Howarth M, Lin W, Ting AY. Site-specific labeling of cell surface proteins with biophysical probes using biotin ligase. Nat Methods. 2005;2:99-104.
21. Diamandis EP, Christopoulos TK. The biotin-(strept)avidin system: principles and applications in biotechnology. Clin Chem. 1991;37: 625-636.
22. Gardner TW. Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy. Trans Am Ophthalmol Soc. 1995;93:583-621.
23. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes. 1998;47:1953-1959.
24. Miyamoto K, Khosrof S, Bursell SE, et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol. 2000;156:1733-1739.
25. Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA. 1999;96:10836-10841.